Literature DB >> 11604235

Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression.

H Yamashita1, M T Nevalainen, J Xu, M J LeBaron, K U Wagner, R A Erwin, J M Harmon, L Hennighausen, R A Kirken, H Rui.   

Abstract

Milk production remains suppressed in mammals during late pregnancy despite high levels of lactogenic polypeptide hormones. At parturition, associated with a precipitous fall in circulating progesterone, rising glucocorticoid levels synergize with prolactin to initiate copious milk production. This synergy is mediated at least in part through the coordinated activation of glucocorticoid receptors and transcription factor Stat5, particularly Stat5a. Here we show that two proline-juxtaposed serine residues within the transactivation domain of Stat5a are phosphorylated in the mammary gland during late gestation and lactation, and that these phosphorylation sites inhibit the transcriptional activity of Stat5a in the absence of glucocorticoid receptor costimulation. Specifically, transfection assays revealed that phosphorylation of residues S725 and S779 of Stat5a cooperatively suppressed prolactin-stimulated transcription from the beta-casein promoter in both COS-7 kidney and MCF-7 mammary cells. This suppression was associated with shortened duration and reduced amplitude of nuclear DNA binding activity of wild type Stat5a relative to that of the serine phosphorylation-defective Stat5 mutant. However, costimulation of glucocorticoid receptors completely reversed the suppressive effect of Stat5a serine phosphorylation on beta-casein gene transcription. We propose that serine phosphorylation within the transactivation domain may limit the activity of Stat5a in the absence of proper coactivation by glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604235     DOI: 10.1016/s0303-7207(01)00546-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  23 in total

1.  Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Authors:  Katrin Friedbichler; Marc A Kerenyi; Boris Kovacic; Geqiang Li; Andrea Hoelbl; Saliha Yahiaoui; Veronika Sexl; Ernst W Müllner; Sabine Fajmann; Sabine Cerny-Reiterer; Peter Valent; Hartmut Beug; Fabrice Gouilleux; Kevin D Bunting; Richard Moriggl
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Yi Liu; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Mol Endocrinol       Date:  2011-08-04

4.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

Review 5.  Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.

Authors:  Mateusz Koptyra; Shilpa Gupta; Pooja Talati; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2011-06-17       Impact factor: 5.085

6.  Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.

Authors:  Zhiyong Liao; Marja T Nevalainen
Journal:  Am J Transl Res       Date:  2010-11-21       Impact factor: 4.060

7.  Involvement of the ubiquitous Oct-1 transcription factor in hormonal induction of beta-casein gene expression.

Authors:  Bing Dong; Feng-Qi Zhao
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

8.  S731 in the transactivation domain modulates STAT5b activity.

Authors:  Amanda M Weaver; Corinne M Silva
Journal:  Biochem Biophys Res Commun       Date:  2007-08-28       Impact factor: 3.575

9.  Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.

Authors:  Jeremy A Ross; Hanyin Cheng; Zsuzsanna S Nagy; Jeffrey A Frost; Robert A Kirken
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

10.  STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Authors:  Zsuzsanna S Nagy; Matthew J LeBaron; Jeremy A Ross; Abhisek Mitra; Hallgeir Rui; Robert A Kirken
Journal:  Mol Cancer       Date:  2009-08-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.